SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories - Quaterly Results

12 Feb 2026 Evaluate
The Turnover for the quarter ended December 2025 of Rs. 547.44 millions increase by 55.40% from Rs. 352.28 millions.Net Profit for the quarter ended December 2025 dipped to Rs. 0.33  millions from Rs. 16.00 millions  in the corresponding previous quarter.Operating profit for the quarter ended December 2025 decreased to 8.59 millions as compared to 12.90 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 547.44 352.28 55.40 1517.39 755.91 100.74 1333.62 1820.52 -26.75
Other Income 6.05 6.66 -9.16 21.22 47.74 -55.55 54.28 96.82 -43.94
PBIDT 8.59 12.90 -33.41 47.99 -37.31 -228.63 7.53 12.73 -40.85
Interest 0.35 0.62 -43.55 2.44 1.21 101.65 1.75 0.78 124.36
PBDT 8.24 12.28 -32.90 45.55 -38.52 -218.25 5.78 11.95 -51.63
Depreciation 7.15 5.09 40.47 17.40 15.19 14.55 20.25 19.48 3.95
PBT 1.09 7.19 -84.84 28.15 -53.71 -152.41 -14.47 -7.53 92.16
TAX 0.76 -8.81 -108.63 7.97 0.17 4588.24 7.02 -10.93 -164.23
Deferred Tax 0.76 -8.81 -108.63 1.85 0.17 988.24 6.46 -1.11 -681.98
PAT 0.33 16.00 -97.94 20.18 -53.88 -137.45 -21.49 3.40 -732.06
Equity 543.12 434.50 25.00 543.12 434.50 25.00 434.50 434.50 0.00
PBIDTM(%) 1.57 3.66 -57.15 3.16 -4.94 -164.08 0.56 0.70 -19.26

Valiant Laboratories Share Price

66.03 -0.97 (-1.45%)
22-Apr-2026 10:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.60
Dr. Reddys Lab 1213.50
Cipla 1227.25
Zydus Lifesciences 926.45
Lupin 2294.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×